From the Editor

The Next Chapter

September 02, 2021

While the players may change, pharma’s patients-first focus should not.

Drug Pricing Scrutiny Increases in Europe

August 02, 2021

Excessive drug pricing is being scrutinized across Europe, as hefty fines are set to send out a clear message of intolerance to anti-competition conduct.

FDA Inspections Back on Track?

August 02, 2021

Congress questions FDA on plans to catch up and move forward with facility inspections.

Avoiding Delays on the Road to Normalcy

July 02, 2021

Vaccines define the path to putting the pandemic in the rear-view mirror.

Identifying Promising COVID-19 Therapies

July 02, 2021

Five therapeutic candidates for the treatment of COVID-19 are identified as promising by the European Commission.

Divest and Conquer? GSK's Future is in Question

June 02, 2021

GSK’s position is raising concerns as it continues working towards its separation of businesses.

A “We are the World” Vaccination Effort?

June 02, 2021

Bio/pharmaceutical manufacturers have made a good first step toward global vaccination through pledging doses at no- to low-profit rates.

Moving Into the Next Phase

May 02, 2021

As face masks start to come off, bio/pharma’s COVID-19 battle goes on.

Acknowledging Bio/Pharma Innovation

May 02, 2021

The world of bio/pharma has been celebrating its achievements across a variety of categories in the latest rounds of awards.

Avoiding Unforced Errors in the Bio/Pharma Industry

April 02, 2021

Smart, accurate, science-based messaging is needed to advance bio/pharma science.